PL330239A1 - Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment - Google Patents

Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment

Info

Publication number
PL330239A1
PL330239A1 PL97330239A PL33023997A PL330239A1 PL 330239 A1 PL330239 A1 PL 330239A1 PL 97330239 A PL97330239 A PL 97330239A PL 33023997 A PL33023997 A PL 33023997A PL 330239 A1 PL330239 A1 PL 330239A1
Authority
PL
Poland
Prior art keywords
reserption
growt
coherent
bone
cyclic
Prior art date
Application number
PL97330239A
Other languages
English (en)
Inventor
Erik Fink Eriksen
Anne-Marie Kappelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL330239A1 publication Critical patent/PL330239A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL97330239A 1996-05-31 1997-05-29 Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment PL330239A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK62396 1996-05-31

Publications (1)

Publication Number Publication Date
PL330239A1 true PL330239A1 (en) 1999-05-10

Family

ID=8095682

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97330239A PL330239A1 (en) 1996-05-31 1997-05-29 Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment

Country Status (14)

Country Link
EP (1) EP0907374A1 (xx)
JP (1) JP2000512274A (xx)
KR (1) KR20000016204A (xx)
CN (1) CN1220609A (xx)
AU (1) AU3025997A (xx)
BR (1) BR9709499A (xx)
CA (1) CA2257174A1 (xx)
CZ (1) CZ383298A3 (xx)
HU (1) HUP9904049A3 (xx)
IL (1) IL126983A0 (xx)
NO (1) NO985573L (xx)
PL (1) PL330239A1 (xx)
WO (1) WO1997046252A1 (xx)
ZA (1) ZA974785B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
EP1093463A1 (en) * 1998-06-09 2001-04-25 Novo Nordisk A/S A method for preparing a compound with growth hormone releasing properties
US6784158B1 (en) 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
JP2001031635A (ja) 1999-07-14 2001-02-06 Ajinomoto Co Inc 光学活性ｎ−保護−ｎ−メチル−フェニルアラニン誘導体の製造方法
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
JP2557779B2 (ja) * 1990-11-26 1996-11-27 アール． レッカー，ロバート ２成分型骨粗鬆症用薬剤
PL314003A1 (en) * 1993-10-19 1996-08-05 Merck & Co Inc Combination of bisulphonates and substances enhancing secretion of growth hormone

Also Published As

Publication number Publication date
ZA974785B (en) 1998-01-22
IL126983A0 (en) 1999-09-22
AU3025997A (en) 1998-01-05
CA2257174A1 (en) 1997-12-11
CZ383298A3 (cs) 1999-07-14
KR20000016204A (ko) 2000-03-25
CN1220609A (zh) 1999-06-23
NO985573L (no) 1999-01-29
EP0907374A1 (en) 1999-04-14
JP2000512274A (ja) 2000-09-19
WO1997046252A1 (en) 1997-12-11
HUP9904049A2 (hu) 2000-04-28
NO985573D0 (no) 1998-11-27
HUP9904049A3 (en) 2000-07-28
BR9709499A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
EP0767624A4 (en) DEVICES AND METHOD FOR PREPARING BONE / TISSUE
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
IL131543A (en) Cosmetic methods and compositions for preventing and treating chronological aging in human skin
ZA976598B (en) IGF-I and insulin formulation
IL125981A0 (en) Improved tissue destruction in cryosurgery
EP1047442A4 (en) BONE MORPHOGENETIC PROTEINS AND THEIR USE IN BONE GROWTH
EP0955874A4 (en) METHOD AND DEVICE FOR IMPEDANCE PLETHYSMOGRAPHY
ZA947138B (en) Skin care method and composition
PL332547A1 (en) Skin care compositions containing an acid and retinoide
HUP9801511A3 (en) Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species
GB2317182B (en) Sulfated polysaccharides and uses thereof in medical treatment
PL330239A1 (en) Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment
GB2325461B (en) Medical sharps and blades removal and containment structure
GB2317980B (en) Analogue multiplier using MOSFETs in nonsaturation region and current mirror
IL120263A0 (en) Combination therapy to prevent bone loss-progesterone and estrogen agonists
AU135003S (en) An abutment for use in dental implant
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
ZA947139B (en) Skin care method and composition
GB9609944D0 (en) An improvement in the treatment of wastes
GB9614958D0 (en) Cosmetic skin treatment and apparatus therefor
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB2338230B (en) Medical sharps and blades removal and containment structure
GB9210405D0 (en) Improvements in and relating to surgical sutures
GB9620530D0 (en) Back and neck treatment device
GB9614230D0 (en) Disposable all in one toothbrush and paste